A cellular sequence containing the integrated human papillomavirus type 16 genome in a cervical carcinoma cell line QG-U was cloned and analysed. The transcriptionally active viral genome disrupted at the E2 and L2 open reading frames was amplified with its flanking sequences.
Certain types of human papillomavirus (HPV) are associated with precancerous cervical intraepithelial neoplasias and carcinomas of the uterine cervix (Diirst et al., 1983; Tomita et al., 1986; Di Luca et al., 1986; Shirasawa et al., 1986) . In particular, HPV type t6 is the most prevalent type and its genomic DNA has been shown to have the ability to transform rodent cells and immortalize human keratinocytes (Yasumoto et al., 1986; Tsunokawa et al., 1986; Dtirst et al., 1987; Pirisi et al., 1987) . In cervical carcinoma tissues, cell lines and in some precancerous lesions, HPV-16 DNA is most often integrated into the host DNA although extrachromosomal viral DNA can persist concurrently (D/irst et al., 1985; Lehn et al., 1985 Lehn et al., , 1988 Pater & Pater, 1985; Yee et al., 1985; Di Luca et al., 1986; Shirasawa et al., 1986) . The integrated HPV-16 genomes have been shown to be disrupted usually at the E1 and E2 region retaining the non-coding region and the E6/E7 region which is transcriptionally active (Lehn et al., 1985; Smotkin & Wettstein, 1986; Shirasawa et al., 1987 Shirasawa et al., , 1988 Awady et al., 1987; Baker et al., 1987; Schneider-Maunoury et al., 1987) . These observations support the hypothesis that the integration of the viral genome plays some role in the development and maintenance of the malignancy.
To know the precise structure of the integration site, the cellular nucleotide sequence containing the integrated HPV-16 genome in the cervical carcinoma cell line QG-U was cloned and analysed. Here we show the precise structure of the integration site, the presence of virushost fused mRNAs and direct evidence of viral genome amplification with its flanking sequences.
QG-U is a cell line derived from a cervical squamous cell carcinoma of a Japanese patient and harbours exclusively integrated HPV-16 genomic DNA which is transcriptionally active as reported previously (Shirasawa et aL, 1987) . Southern blot analysis of the QG-U DNA with restriction enzymes BamHI, HindlII, EcoRI and PstI (single-cut, no-cut, two-cut and six-cut enzymes for HPV-16 DNA, respectively) using HPV-16 DNA as a probe showed that the viral genome is monomeric and integrated at a single site (Shirasawa et al., 1987) (Fig. 1) . The viral genome was judged to be interrupted at the 1.1 kb PstI fragment region which contains the 3' portion of the E2 open reading frame (ORF) and the 5' portion of the L20RF, as indicated by the absence of the 1.1 kb PstI fragment (Fig. 1, lane 4) . Although the HindlII cleavage yielded a single fragment containing the viral genome (Fig. 1, lane 2) , the fragment was 22 kb in size and too large to introduce into the 3~ phage vector. Therefore, we chose to introduce the two BamHI fragments hybridizing to HPV-16 DNA (11 kb and 7 kb as shown in Fig. 1, lane 1) The DNA extracted from t)G-U cells was treated with BamHI and fractionated on a 0.5~ agarose gel. The gel was sliced and individual DNA fractions were eluted and recovered by DNACELL (Daiichi Pure Chemicals) as recommended by the manufacturer. The DNA fractions that hybridized to HPV-16 DNA were introduced into 2 L47-1 DNA at the BamHI site. The ligated DNAs were packaged in vitro with Gigapack Gold (Stratagene) for the construction of enriched partial genomic libraries. Approximately 5 x 10 s recombinant phages for the 7 kb inserts and 1 × 106 recombinant phages for the 11 kb inserts were plated on a P2 lysogen, WL95, as host and screened by plaque hybridization using HPV-16 DNA as a probe. One positive clone (UD913) for the 7 kb fragment and eight positive clones for the 11 kb fragment were obtained. Four clones (UU111, UU211, UU311, UU411) out of the eight clones for the 11 kb fragment were analysed by digestion with restriction enzymes and proved to be identical. The UD913 and UU411 inserts were subcloned into the BamHI site of pUC19 and used for further analyses.
The restriction map of UD913 and UU411 is depicted in Fig. 2 (a). The recognition sites for several restriction enzymes were the same as for the prototype HPV-16 except for the HincI1 site in the non-coding region (Fig. 2a , Hc*). Neither large duplications nor internal deletions were detected by restriction enzyme analysis. This analysis indicated that the 5' and 3' virus-host junctions are located at the 5' end of the L 2 0 R F and the 3' end of the E 2 0 R F , respectively. The E4 ORF was intact and the E5 ORF was entirely deleted. To identify more precisely the site of the virus-host junctions, the nucleotide sequences around the junctions were determined by the dideoxynucleotide chain-termination sequencing method (Sanger et al., 1980) using an M13-specific oligonucleotide primer after introducing the various DNA fragments into M13mpl8 and M13mpl9. Sequence analyses revealed that the virus-host junctions reside at nucleotide positions 3741 (E20RF) and 4416 (L20RF). Part, 674 bp, of the viral genome (nucleotides 3742 to 4415) containing the putative early polyadenylation signal, was deleted. The nucleotide sequences of the virus-host junctions are shown in Fig. 3 . Around the 5' junction, no significant homology was found between the host and the viral sequences, but an AT-rich region was present in the flanking sequence (Fig. 3a) . Around the 3' junction, a TAAAA/TTTTA 5 bp inverted repeat was present (Fig. 3b) generated at either the 5' or 3' viral terminus as a result of integration. The E20RF was terminated 55 nucleotides downstream from the junction as shown in Fig. 3(b) .
We determined 1449 bp of the 3' flanking sequence, 568 bp of the 5' flanking sequence and approximately 1.6 kb of the viral sequence including the non-coding region, and the E2, L2, E6 and E70RFs. There was no large ORF in the flanking host sequences. A homology search in Genbank revealed that the 3' flanking sequence has no homology to known sequences. However, the 5' flanking sequence, 357 bp upstream from the junction, contains 190 bp which show high Short communication homology to part of the 350 bp 'O' family repeat. Polyadenylation signals, AATAAA, were found at 855 bp and 864 bp downstream from the 3'junction; these might be used by the virushost fused mRNAs. In the sequenced portion of the viral genome, four nucleotide changes were found in comparison with the published prototype HPV-16 sequence (Seedorf et al., 1985) as shown in Table 1 . One of the changes in the E70RF at the nucleotide position 846 was the same as that reported by Choo et al. (1988) .
To elucidate how the integration of the HPV genome occurred, we analysed QG-U DNA by Southern blotting using the flanking cellular sequences, UUh (BgllI-SpeI fragment of UU411) and UDh (EcoRI-HindlII fragment of UD913) which are indicated in Fig. 2(a) . The 513 bp UUh contains 153 bp of viral sequence. The cellular DNA was digested with the indicated restriction enzymes and analysed. The QG-U DNA showed heterozygosity, indicating that the allelic cellular sequence unaltered by HPV DNA integration is present (Fig. 4) . The existence of the same allelic cellular sequence in normal human fibroblasts was revealed by Southern blot analysis with several restriction enzymes (data not shown). These analyses allowed us to map the intact allelic cellular sequence as depicted in Fig. 2 (b) . From these results it appears that 5.6 kb of the cellular sequence was deleted at the integration site. In addition, the hybridization signals of the fragments from the allelic cellular sequence were weaker than those of the fragments from the viral DNA and its flanking sequences, indicating that the viral genome is amplified with its flanking sequences. The magnitude of this amplification was estimated by cutting out the 32p_ labelled portion of the filter corresponding to the fragments a and b shown in the Fig. 4 (b) and counting in liquid scintillant. Fragment b, which consists of both the 3' flanking sequence and the unaltered sequence, was four times as radioactive as fragment a, revealing that the viral genome and its flanking sequences are present as three copies per diploid genome.
As a result of the integration, the viral genome lacks the putative early polyadenylation signal and this seemingly causes the viral transcripts to be a chimeric mRNA of virus and flanking cellular sequences as reported previously (Shirasawa et al., 1987 (Shirasawa et al., , 1988 . To confirm this and to see whether the flanking sequence is transcribed in normal cells, total RNA was extracted from QG-U cells and from a primary culture of human fibroblasts, and subjected to Northern blot analysis using the 3' flanking sequence UDh as a probe. As shown in Fig. 5 , there was no transcript hybridizing to the host DNA sequence in normal human fibroblasts. The 3.6 kb and 2.0 kb transcripts which hybridized to the E6/E7 region also hybridized to the UDh, suggesting that these mRNAs were generated by readthrough into the flanking sequence. The other viral transcripts did not hybridize to UDh, suggesting that this region is spliced out in these transcripts which terminate further downstream.
The alteration of the structure in viral transcripts by readthrough into the flanking sequence may have some biological meaning (Shirasawa et al., 1988) , for instance stabilization ofmRNA. Indeed, an increase in the half-life of the viral transcripts in HeLa cells has been observed (Schwarz et al., 1985; Schneider-G/idicke & Schwarz, 1986; Kleiner et al., 1986) . The transcriptional regulation of the viral genome may also be altered. In CaSki and QG-H cells which have tandem repeat HPV-16 copies, the viral transcripts do not utilize the viral polyadenylation signals (Smotkin & Wettstein, 1986; Shirasawa et al., 1988) . The deregulation of viral transcription by integration as well as by cellular events might be necessary for carcinogenesis. This integration seems to need no specific site in either viral or cellular sequences. Our data and previously reported junction sequences (Awady et al., 1987; Baker et al., 1987; Schneider-Maunoury et al., 1987; Choo et al., 1988) indicate that, like that of other viruses, integration of HPV-16 D N A is mediated by a mechanism of illegitimate re~,ombination with very short homologous stretches (Ruley & Fried, 1983) . The effect of the cellular sequence on the viral genome must also be taken into conskteration. The 5' flanking sequences including the incomplete 'O' family repeat could perhaps modulate viral transcription. The 'O' family repeat is thought to be long terminal repeat-like sequence of a transposon-like element (Paulson et al., 1985) .
The process of carcinogenesis may be triggered by the deletion or inactivation of cellular genes such as tumour suppressor genes. In Q G -U cells, approximately 5.6 kb of the cellular sequence was deleted at the integration site. The deleted cellular sequence, however, seems to be inactive because the flanking sequence is not transcribed in normal human fibroblast cells. The amplification of the viral genome could be an early event, as the integration can occur in the precancerous stage (Di Luca et al., 1986; Shirasawa et al., 1986; Schneider-Maunoury et al., 1987; Lehn et al., 1988) . In fact, this phenomenon is not unusual, because the integrated monomeric viral genomes often exist as several copies even if the integration site is estimated to be single. This event might enhance cell proliferation. The amplification of the transcriptionally active HPV-16 genome suggests the involvement of the HPV-16 genomes in the development and maintenance of the malignancy.
